Invacare Corporation announced that its production efforts will not be slowed by a recent warning letter from the Food and Drug Administration. “Our customers and patients can continue to rely upon the safety and quality of our products, just as they have for more than 30 years,” the firm noted on its website. The warning letter alleged failure to report electric bed malfunctions. “Invacare is taking the FDA’s concerns very seriously and will address them appropriately,” the firm added.